IMMUNOtherapy and Stereotactic ABlative Radiotherapy (IMMUNOSABR) a Phase II Study

Clinical trial NCT03705403 · TERMINATED

Trial details

NCT number: NCT03705403
Sponsor: Maastricht University Medical Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

NSCLC Stage IV Metastatic Disease

Start date: 2019-04-04
Primary completion: 2025-01-06
Enrollment: 88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.